Dostarlimab monotherapy in mismatch repair deficient/microsatellite instability-high advanced or recurrent endometrial cancer in the Korean expanded access program

被引：0
|
作者：
Park, Soo Jin [1 ]
Lee, Yoo Young [2 ]
Kim, Kidong [3 ]
Nam, Eun Ji [4 ]
Lim, Myong Cheol [5 ]
Kim, Min Kyu [6 ]
Kim, Ki Hyung [7 ]
Kwon, Yong-Soon [8 ]
机构：
[1] Seoul Natl Univ Hosp, Obstet & Gynecol, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Gynecol Canc Ctr, Dept Obstet & Gynecol,Sch Med, Seoul, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam Si, South Korea
[4] Yonsei Univ, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Div Gynecol Oncol,Coll Med, Seoul, South Korea
[5] Natl Canc Ctr, Ctr Gynecol Canc, Goyang, South Korea
[6] Sungkyunkwan Univ, Samsung Changwon Hosp, Sch Med, Dept Obstet & Gynecol, Chang Won, South Korea
[7] Pusan Natl Univ Hosp, Obstet & Gynecol, Busan, South Korea
[8] Eulji Univ, Coll Med, Nowon Eulji Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期
关键词：
D O I：
10.1136/ijgc-2023-IGCS.230
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP134
引用
收藏
页码：A131 / A132
页数：2
相关论文
共 50 条
  • [41] PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY
    Baldini, Capucine
    Cassier, Philippe A.
    Delord, Jean-Pierre
    Simonelli, Matteo
    Touat, Mehdi
    Yao, Lili
    Duic, J. Paul
    Gozman, Alexander
    Marabelle, Aurelien
    NEURO-ONCOLOGY, 2022, 24 : 59 - 60
  • [42] Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
    Pei, Fengyun
    Wu, Jingjing
    Zhao, Yandong
    He, Wan
    Yao, Qijun
    Huang, Meijin
    Huang, Jun
    CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 85 - 91
  • [43] Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer
    Oh, Chung Ryul
    Kim, Jeong Eun
    Hong, Yong Sang
    Kim, Sun Young
    Ahn, Joong Bae
    Baek, Ji Yeon
    Lee, Myung-Ah
    Kang, Myoung Joo
    Cho, Sang Hee
    Beom, Seung-Hoon
    Kim, Tae Won
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (12) : 2038 - 2045
  • [44] Pembrolizumab in Patients of Chinese Descent with Microsatellite Instability-high/Mismatch Repair Deficient Advanced Solid Tumors: KEYNOTE-158 Final Analysis
    Wu, Xiaohua
    Mao, Yimin
    Xu, Nong
    Bai, Yuxian
    Wang, Dong
    Chen, Xiaojun
    Yin, Xianli
    Deng, Yanhong
    Yang, Jianwei
    Zhang, Jieqing
    Tang, Jie
    Huang, Yi
    Li, Jiayi
    Luo, Suxia
    Zheng, Hong
    Zhao, Weidong
    Xu, Miaomiao
    Li, Nan
    Mao, Yixiang
    Gozman, Alexander
    Xu, Jianming
    ADVANCES IN THERAPY, 2025, : 2480 - 2489
  • [45] Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
    Overman, Michael J.
    Lonardi, Sara
    Wong, Ka Yeung Mark
    Lenz, Heinz-Josef
    Gelsomino, Fabio
    Aglietta, Massimo
    Morse, Michael A.
    Van Cutsem, Eric
    McDermott, Ray
    Hill, Andrew
    Sawyer, Michael B.
    Hendlisz, Alain
    Neyns, Bart
    Svrcek, Magali
    Moss, Rebecca A.
    Ledeine, Jean-Marie
    Cao, Z. Alexander
    Kamble, Shital
    Kopetz, Scott
    Andre, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 773 - +
  • [46] KEYNOTE-158: Final analysis of pembrolizumab in patients of Chinese descent with microsatellite instability-high/mismatch repair deficient advanced solid tumors
    Xu, Jianming
    Mao, Yimin
    Xu, Nong
    Bai, Yuxian
    Wang, Dong
    Chen, Xiaojun
    Yin, Xianli
    Deng, Yanhong
    Yang, Jianwei
    Zhang, Jieqing
    Tang, Jie
    Huang, Yi
    Li, Jiayi
    Luo, Suxia
    Xu, Miaomiao
    Li, Nan
    Mao, Yixiang
    Gozman, Alexander
    Wu, Xiaohua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal Cancer: A Preliminary Report of Case Series
    Pan, Tao
    Yang, Hui
    Wang, Wu-yi
    Rui, Yuan-yi
    Deng, Zi-jian
    Chen, Yung-chang
    Liu, Chao
    Hu, Hai
    CLINICAL COLORECTAL CANCER, 2024, 23 (01) : 104 - 110
  • [48] Cost-effectiveness analysis of pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer
    Liu, Tong
    Liu, Shuang
    Guan, Shangwei
    Tai, Yu
    Jin, Yao
    Dong, Mei
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (08) : 745 - 752
  • [49] The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
    Wang, Qiao-Xuan
    Qu, Chun-Hua
    Gao, Yuan-Hong
    Ding, Pei-Rong
    Yun, Jing-Ping
    Xie, Dan
    Cai, Mu-Yan
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [50] The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
    Qiao-Xuan Wang
    Chun-Hua Qu
    Yuan-Hong Gao
    Pei-Rong Ding
    Jing-Ping Yun
    Dan Xie
    Mu-Yan Cai
    Experimental Hematology & Oncology, 10
12345